英文摘要 |
Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal tumor, can arise from various anatomic sites. This study aimed to evaluate the clinic-pathological characteristics of patients with malignant PEComa arising from the female genital tract. A retrospective study was conducted in Taipei Veterans General Hospital (Taipei VGH) between 2008 and 2018. All published English cases based on the Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) statement were also included in the current review. A total of 114 women from PRISMA and 3 women from Taipei VGH were identified. The uterus was the most commonly involved site (82/114, 71.9%), followed by the cervix (12/114, 10.5%). Immunohistochemical staining showed that nearly all gynecological PEComas were positive for human melanoma black 45 (113/114, 99.1%). More than half of the gynecological PEComas were immune-reactive for desmin (50/85, 58.8%). Our results showed an optimal cytoreductive surgery, and mammalian target of rapamycin (mTOR) inhibitors for aggressive tumor behavior as targeted therapy, provided long-term disease-free survival (cure rate ranging from 50% to 100%, based on the different anatomic sites of the female genital tract). In conclusion, multi-modality treatment, including cytoreductive surgery and mTOR inhibitors with/without chemotherapy and/ or radiation, should be considered for the management of women with PEComas in the female genital tract with aggressive behavior. |